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S U M M A R Y
Several countries in the Middle East and around 22 countries worldwide have reported cases of human
infection with the Middle East respiratory syndrome coronavirus (MERS-CoV). The exceptionally high
fatality rate resulting from MERS-CoV infection in conjunction with the paucity of knowledge about this
emerging virus has led to major public and international concern. Within the framework of the national
acute respiratory illness surveillance, the Ministry of Health in the Sultanate of Oman has announced two
conﬁrmed cases of MERS-CoV to date. The aim of this report is to describe the epidemiological aspects of
these two cases and to highlight the importance of public health preparedness and response. The
absence of secondary cases among contacts of the reported cases can be seen as evidence of the
effectiveness of infection prevention and control precautions as an important pillar of the national
preparedness and response plan applied in the health care institutions in Oman.
 2014 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Several countries worldwide have reported cases of human
infection with the Middle East respiratory syndrome coronavirus
(MERS-CoV). The exceptionally high fatality rate resulting from
MERS-CoV infection in conjunction with the paucity of knowledge
about this emerging virus has led to major public and international
concern.1 The Ministry of Health in the Sultanate of Oman has
announced two conﬁrmed cases of MERS-CoV. The aim of this
report is to describe the epidemiological aspects of the reported
MERS-CoV cases in Oman and to highlight the public health
response and the activities done to face any future resurgence of
MERS-CoV in the country.
2. MERS-CoV in Oman
Based on the World Health Organization (WHO) interim
case deﬁnition for MERS-CoV as of July 3, 2013,2 the ﬁrst* Corresponding author.
E-mail address: dr.idris.oman@gmail.com (I.S. Al-Abaidani).
http://dx.doi.org/10.1016/j.ijid.2014.10.003
1201-9712/ 2014 Published by Elsevier Ltd on behalf of International Society for Infect
creativecommons.org/licenses/by-nc-nd/3.0/).laboratory-conﬁrmed case of MERS-CoV in Oman was diagnosed
on October 29, 2013. A 68-year-old Omani man from Dakhliyah
Governorate complained of fever and cough of 2-day duration. He
then developed right lower lobe pneumonia and multi-organ
failure and died on November 10, 2013. He had a history of type
2 diabetes mellitus and uncontrolled hypertension, and he had
previously undergone coronary artery bypass grafting. He did not
have a history of travel outside the country or contact with
animals.
The second case was a 59-year-old Omani man from North
Batinah Governorate who presented on December 22, 2013 with a
high-grade temperature and cough of 6-day duration. He later
developed severe right upper lobe pneumonia and died on
December 30, 2013. He was a heavy smoker, but had no known
medical comorbidities. The patient had attended a camel race in
Abu Dhabi, UAE, 4 weeks before the onset of his symptoms.
3. MERS-CoV preparedness and response
The Ministry of Health implemented a national MERS-CoV
preparedness and response plan. This plan was based onious Diseases. This is an open access article under the CC BY-NC-ND license (http://
I.S. Al-Abaidani et al. / International Journal of Infectious Diseases 29 (2014) 309–310310strengthening ﬁve pillars of action, including public health
surveillance and contact management, building laboratory capac-
ity, infection prevention and control, case management, and risk
communication. Algorithms were developed describing response
actions in the event of a suspected MERS-CoV case. Checklists for
the preparedness of health care facilities were developed and
action plans were later developed to rectify the deﬁciencies.
Field visits were conducted immediately after conﬁrmation of
cases by the regional and national rapid response teams from the
Ministry of Health, and contact surveillance and monitoring was
conducted for 14 days after the last exposure. Laboratory
surveillance for MERS-CoV started by building laboratory diagnos-
tic capacity with the availability of the primers for MERS-CoV
testing, and with the training of laboratory personnel countrywide
on the triple-packing and shipment of samples. Training on how to
collect nasopharyngeal swabs for testing for MERS-CoV was
conducted for emergency room physicians, internists, and
intensivists in all district hospitals.
National infection prevention and control guidelines were
developed for dealing with suspected or conﬁrmed cases of MERS-
CoV. Mask-ﬁt testing was done for all healthcare workers who
could be involved in taking care of patients with MERS-CoV. A
project was initiated for triaging of patients presenting to
emergency rooms or health centers with an acute respiratory
illness.
In 2013, post Hajj surveillance for MERS-CoV was done using
nasopharyngeal swabs for people returning from Hajj and
presenting with respiratory symptoms. Three hundred and ﬁfty
samples were tested by real-time PCR and all were negative for
MERS-CoV.The surveillance system for severe acute respiratory infections
(SARI) was implemented in Oman in January 2008 in four regional
hospitals as sentinel sites; SARI aims to determine the epidemiol-
ogy of severe respiratory infections and the contribution of
inﬂuenza and other etiological agents to severe respiratory
infections in the country.3 It also aims to detect emergent
inﬂuenza strains with pandemic potential or any other respiratory
infections, and to detect any unusual morbidity or mortality due to
acute respiratory illness. In 2012, SARI sentinel sites were used as a
platform to test 10% of cases for MERS-CoV at the central public
health laboratory; 2000 samples were tested and all were negative.
In conclusion, we have described the epidemiological aspects of
the two reported cases of MERS-CoV in Oman and the prepared-
ness efforts made by the Ministry of Health. Strengthened infection
control practices and having a powerful active surveillance
program for acute respiratory illnesses is key to the rapid and
prompt response for emerging respiratory infections.
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